225 related articles for article (PubMed ID: 33520717)
1. MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways.
Zhang X; Wang J; Wang Y; Liu G; Li H; Yu J; Wu R; Liang J; Yu R; Liu X
Front Oncol; 2020; 10():608082. PubMed ID: 33520717
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
Zhang Y; Zhou X; Li Y; Xu Y; Lu K; Li P; Wang X
Oncogene; 2018 Oct; 37(41):5520-5533. PubMed ID: 29895969
[TBL] [Abstract][Full Text] [Related]
3. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.
Joshi K; Banasavadi-Siddegowda Y; Mo X; Kim SH; Mao P; Kig C; Nardini D; Sobol RW; Chow LM; Kornblum HI; Waclaw R; Beullens M; Nakano I
Stem Cells; 2013 Jun; 31(6):1051-63. PubMed ID: 23404835
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways.
Zhang X; Wang J; Wang Y; Liu G; Li H; Yu J; Wu R; Liang J; Yu R; Liu X
Front Oncol; 2022; 12():911817. PubMed ID: 35530328
[TBL] [Abstract][Full Text] [Related]
5. Multi-kinase inhibitor C1 triggers mitotic catastrophe of glioma stem cells mainly through MELK kinase inhibition.
Minata M; Gu C; Joshi K; Nakano-Okuno M; Hong C; Nguyen CH; Kornblum HI; Molla A; Nakano I
PLoS One; 2014; 9(4):e92546. PubMed ID: 24739874
[TBL] [Abstract][Full Text] [Related]
6. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
Maes A; Maes K; Vlummens P; De Raeve H; Devin J; Szablewski V; De Veirman K; Menu E; Moreaux J; Vanderkerken K; De Bruyne E
Blood Cancer J; 2019 Nov; 9(12):87. PubMed ID: 31740676
[TBL] [Abstract][Full Text] [Related]
7. MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells.
Kohler RS; Kettelhack H; Knipprath-Mészaros AM; Fedier A; Schoetzau A; Jacob F; Heinzelmann-Schwarz V
Gynecol Oncol; 2017 Apr; 145(1):159-166. PubMed ID: 28214016
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma.
Cigliano A; Pilo MG; Mela M; Ribback S; Dombrowski F; Pes GM; Cossu A; Evert M; Calvisi DF; Utpatel K
Medicina (Kaunas); 2019 Dec; 56(1):. PubMed ID: 31861475
[No Abstract] [Full Text] [Related]
9. MELK Inhibition in Diffuse Intrinsic Pontine Glioma.
Meel MH; de Gooijer MC; Guillén Navarro M; Waranecki P; Breur M; Buil LCM; Wedekind LE; Twisk JWR; Koster J; Hashizume R; Raabe EH; Montero Carcaboso A; Bugiani M; van Tellingen O; van Vuurden DG; Kaspers GJL; Hulleman E
Clin Cancer Res; 2018 Nov; 24(22):5645-5657. PubMed ID: 30061363
[No Abstract] [Full Text] [Related]
10. Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway.
Nakano I; Joshi K; Visnyei K; Hu B; Watanabe M; Lam D; Wexler E; Saigusa K; Nakamura Y; Laks DR; Mischel PS; Viapiano M; Kornblum HI
Neuro Oncol; 2011 Jun; 13(6):622-34. PubMed ID: 21558073
[TBL] [Abstract][Full Text] [Related]
11. MELK is a novel therapeutic target in high-risk neuroblastoma.
Guan S; Lu J; Zhao Y; Yu Y; Li H; Chen Z; Shi Z; Liang H; Wang M; Guo K; Chen X; Sun W; Bieerkehazhi S; Xu X; Sun S; Agarwal S; Yang J
Oncotarget; 2018 Jan; 9(2):2591-2602. PubMed ID: 29416794
[TBL] [Abstract][Full Text] [Related]
12. A novel carbon-11 radiolabeled maternal embryonic leucine zipper kinase inhibitor for PET imaging of triple-negative breast cancer.
Tang R; Gai Y; Li K; Hu F; Gong C; Wang S; Feng F; Altine B; Hu J; Lan X
Bioorg Chem; 2021 Feb; 107():104609. PubMed ID: 33454507
[TBL] [Abstract][Full Text] [Related]
13. [Effect of MELK Inhibitor OTSSP167 on Diffuse Large B-Cell Lymphoma].
Zhou JY; Huang H; Zhuang Y; Zhong XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):739-745. PubMed ID: 37356934
[TBL] [Abstract][Full Text] [Related]
14. Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma.
Bolomsky A; Heusschen R; Schlangen K; Stangelberger K; Muller J; Schreiner W; Zojer N; Caers J; Ludwig H
Haematologica; 2018 Feb; 103(2):325-335. PubMed ID: 29122991
[TBL] [Abstract][Full Text] [Related]
15. Emerging targets for glioblastoma stem cell therapy.
Safa AR; Saadatzadeh MR; Cohen-Gadol AA; Pollok KE; Bijangi-Vishehsaraei K
J Biomed Res; 2016 Jan; 30(1):19-31. PubMed ID: 26616589
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
17. Maternal embryonic leucine zipper kinase: key kinase for stem cell phenotype in glioma and other cancers.
Ganguly R; Hong CS; Smith LG; Kornblum HI; Nakano I
Mol Cancer Ther; 2014 Jun; 13(6):1393-8. PubMed ID: 24795222
[TBL] [Abstract][Full Text] [Related]
18. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
19. SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells.
Tao W; Zhang A; Zhai K; Huang Z; Huang H; Zhou W; Huang Q; Fang X; Prager BC; Wang X; Wu Q; Sloan AE; Ahluwalia MS; Lathia JD; Yu JS; Rich JN; Bao S
EMBO Mol Med; 2020 Dec; 12(12):e12291. PubMed ID: 33124191
[TBL] [Abstract][Full Text] [Related]
20. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]